following a full submission
fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall®) is accepted for use within NHS Scotland.
Indication under review: the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.
Fluorouracil 0.5% / salicylic acid 10% cutaneous solution was superior to another topical treatment for the histological clearance of a specified target actinic keratosis lesion.
Download detailed advice138KB (PDF)
- Medicine name:
- fluorouracil + salicylic acid (Actikerall)
- SMC ID:
- For the topical treatment of hyperkeratotic actinic keratosis.
- Pharmaceutical company
- Almirall Ltd
- BNF chapter
- Submission type
- Date advice published
- 10 October 2011